ABOUT US

BioMedha is a UK-based, preclinical contract research organisation (CRO) providing bioscience expertise to pharmaceutical and biotechnology companies worldwide.
Based at BioCity Nottingham, we support early stage drug discovery and development programmes by delivering high-quality cell-based and in vitro research services.

Our team comprises industry-experienced, in vitro biology-focused scientists who work closely with clients to undertake key elements of the early-stage drug discovery process. Through scientific rigour, technical expertise and collaborative working, we help our partners generate reliable data to support informed decision-making.

Supporting clients across pharma, biotech, virtual companies, as well as spin outs and academia, our passionate team of scientists brings substantial pre-clinical drug discovery biology experience.

Our scientific capabilities

BioMedha provides portfolio of preclinical bioscience services, including:

How we work

We work as an extension of our clients’ scientific teams, tailoring each study to the specific research question and programme objectives.

Our approach is defined by:

Scientific rigour

Carefully designed assays and reproducible data

Collaboration

Open communication throughout each project

Flexibility

Adapting study design as programmes evolve

Transparency

Clear reporting and interpretation of results

Why BioMedha

Clients choose BioMedha for our:

Whether supporting a single assay or a broader discovery programme, we aim to add measurable value at every stage of the research process.

The story behind our name:

BioMedha comes from Bio (Greek for biology) and Medha (sanskrit for knowledge and rationale). Our scientists combine their expertise and knowledge in discovery biology to provide greater understanding in drug discovery.

Speak to our team

If you would like to discuss how BioMedha can support your drug discovery programme, please get in touch with our team to explore your requirements.